受强制性开放获取政策约束的文章 - Gregory W Roloff了解详情
可在其他位置公开访问的文章：18 篇
Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair
A Shabbir, D Zisa, H Lin, M Mastri, G Roloff, G Suzuki, T Lee
American Journal of Physiology-Heart and Circulatory Physiology 299 (5 …, 2010
强制性开放获取政策： US National Institutes of Health
NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome
EA Griffiths, P Srivastava, J Matsuzaki, Z Brumberger, ES Wang, J Kocent, ...
Clinical Cancer Research 24 (5), 1019-1029, 2018
强制性开放获取政策： US National Institutes of Health, Doris Duke Charitable Foundation
Technical advances in the measurement of residual disease in acute myeloid leukemia
GW Roloff, C Lai, CS Hourigan, LW Dillon
Journal of clinical medicine 6 (9), 87, 2017
强制性开放获取政策： US National Institutes of Health, Doris Duke Charitable Foundation
Targeted RNA-sequencing for the quantification of measurable residual disease in acute myeloid leukemia
LW Dillon, S Hayati, GW Roloff, I Tunc, M Pirooznia, A Mitrofanova, ...
Haematologica 104 (2), 297, 2019
强制性开放获取政策： US National Institutes of Health, Doris Duke Charitable Foundation
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
C Saygin, G Roloff, CN Hahn, R Chhetri, S Gill, H Elmariah, C Talati, ...
Blood Advances 7 (4), 549-554, 2023
强制性开放获取政策： US National Institutes of Health, National Health and Medical Research …
Tissue-of-origin-specific gene repositioning in breast and prostate cancer
KJ Meaburn, O Agunloye, M Devine, M Leshner, GW Roloff, LD True, ...
Histochemistry and cell biology 145, 433-446, 2016
强制性开放获取政策： US National Institutes of Health
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies
GW Roloff, LA Godley, MW Drazer
Genetics in Medicine 23 (1), 211-214, 2021
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation
Locus-specific gene repositioning in prostate cancer
M Leshner, M Devine, GW Roloff, LD True, T Misteli, KJ Meaburn
Molecular biology of the cell 27 (2), 236-246, 2016
强制性开放获取政策： US National Institutes of Health
Molecular measurable residual disease testing of blood during AML cytotoxic therapy for early prediction of clinical response
HY Wong, AD Sung, KE Lindblad, S Sheela, GW Roloff, D Rizzieri, ...
Frontiers in oncology 8, 669, 2019
强制性开放获取政策： US National Institutes of Health
Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell ALL: Outcomes and Novel Insights from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
GW Roloff, I Aldoss, NE Kopmar, C Lin, SE Dekker, VK Gupta, ...
Blood 142, 1030, 2023
强制性开放获取政策： US National Institutes of Health
Stagnation in quality of next‐generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies
GW Roloff, R Shaw, TE O'Connor, F Hathaway, MW Drazer
Journal of Genetic Counseling, 2023
强制性开放获取政策： US National Institutes of Health
The Impact of Inotuzumab Ozogamicin (InO) Treatment on Brexucabtagene Autoleucel (Brexu-cel) Outcomes in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL)
I Aldoss, GW Roloff, AS Advani, NE Kopmar, C Lin, SE Dekker, VK Gupta, ...
Blood 142, 4877, 2023
强制性开放获取政策： US National Institutes of Health
Bridging Therapy in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Receiving Standard of Care Brexucabtagene Autoleucel: Results from the Real-World …
C Lin, SB Tsai, GW Roloff, A Zhang, I Aldoss, NE Kopmar, SE Dekker, ...
Blood 142, 3502, 2023
强制性开放获取政策： US National Institutes of Health
Multicenter analysis of immunosuppressive medications on the risk of malignancy following adult solid organ transplantation
R Shaw, AR Haque, T Luu, TE O’Connor, A Hamidi, J Fitzsimons, B Varda, ...
Frontiers in Oncology 13, 1146002, 2023
强制性开放获取政策： US National Institutes of Health
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes
A Hamidi, GW Roloff, R Shaw, M Acevedo, S Smith, MW Drazer
Leukemia & Lymphoma, 1-4, 2023
强制性开放获取政策： US National Institutes of Health
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors
GW Roloff, F Wen, A Ramsland, AS Artz, S Kosuri, W Stock, O Odenike, ...
Haematologica, 2023
强制性开放获取政策： US National Institutes of Health
Toxicity Profile of Brexucabtagene Autoleucel (brexu-cel; CD19-directed CAR T-cell therapy) in Adult Patients (pts) with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic …
NE Kopmar, T Gooley, GW Roloff, I Aldoss, C Lin, SE Dekker, VK Gupta, ...
Blood 142, 522, 2023
强制性开放获取政策： US National Institutes of Health
Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation
GW Roloff, S Kosuri, MT Nawas, AS DuVall, AA Patel, PA Riedell, ...
Haematologica, 2020
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定